Original Research Online Publishing Date: | ||||||||||||
Effectiveness and safety of ormeloxifene and medroxyprogesterone acetate in dysfunctional uterine bleeding A prospective interventional quasi-randomized interval clinical study Arathy R, Santosh Pillai, Sreedevi N S, Rajeev Aravindakshan, Rajmohan G, Sujith J Chandy.
|
How to Cite this Article |
Pubmed Style R A, Pillai S, S SN, Aravindakshan R, G R, Chandy SJ. Effectiveness and safety of ormeloxifene and medroxyprogesterone acetate in dysfunctional uterine bleeding A prospective interventional quasi-randomized interval clinical study. Natl J Physiol Pharm Pharmacol. 2021; 11(3): 246-252. doi:10.5455/njppp.2021.11.10285202024102020 Web Style R A, Pillai S, S SN, Aravindakshan R, G R, Chandy SJ. Effectiveness and safety of ormeloxifene and medroxyprogesterone acetate in dysfunctional uterine bleeding A prospective interventional quasi-randomized interval clinical study. https://www.njppp.com/?mno=17666 [Access: March 14, 2024]. doi:10.5455/njppp.2021.11.10285202024102020 AMA (American Medical Association) Style R A, Pillai S, S SN, Aravindakshan R, G R, Chandy SJ. Effectiveness and safety of ormeloxifene and medroxyprogesterone acetate in dysfunctional uterine bleeding A prospective interventional quasi-randomized interval clinical study. Natl J Physiol Pharm Pharmacol. 2021; 11(3): 246-252. doi:10.5455/njppp.2021.11.10285202024102020 Vancouver/ICMJE Style R A, Pillai S, S SN, Aravindakshan R, G R, Chandy SJ. Effectiveness and safety of ormeloxifene and medroxyprogesterone acetate in dysfunctional uterine bleeding A prospective interventional quasi-randomized interval clinical study. Natl J Physiol Pharm Pharmacol. (2021), [cited March 14, 2024]; 11(3): 246-252. doi:10.5455/njppp.2021.11.10285202024102020 Harvard Style R, A., Pillai, . S., S, . S. N., Aravindakshan, . R., G, . R. & Chandy, . S. J. (2021) Effectiveness and safety of ormeloxifene and medroxyprogesterone acetate in dysfunctional uterine bleeding A prospective interventional quasi-randomized interval clinical study. Natl J Physiol Pharm Pharmacol, 11 (3), 246-252. doi:10.5455/njppp.2021.11.10285202024102020 Turabian Style R, Arathy, Santosh Pillai, Sreedevi N S, Rajeev Aravindakshan, Rajmohan G, and Sujith J Chandy. 2021. Effectiveness and safety of ormeloxifene and medroxyprogesterone acetate in dysfunctional uterine bleeding A prospective interventional quasi-randomized interval clinical study. National Journal of Physiology, Pharmacy and Pharmacology, 11 (3), 246-252. doi:10.5455/njppp.2021.11.10285202024102020 Chicago Style R, Arathy, Santosh Pillai, Sreedevi N S, Rajeev Aravindakshan, Rajmohan G, and Sujith J Chandy. "Effectiveness and safety of ormeloxifene and medroxyprogesterone acetate in dysfunctional uterine bleeding A prospective interventional quasi-randomized interval clinical study." National Journal of Physiology, Pharmacy and Pharmacology 11 (2021), 246-252. doi:10.5455/njppp.2021.11.10285202024102020 MLA (The Modern Language Association) Style R, Arathy, Santosh Pillai, Sreedevi N S, Rajeev Aravindakshan, Rajmohan G, and Sujith J Chandy. "Effectiveness and safety of ormeloxifene and medroxyprogesterone acetate in dysfunctional uterine bleeding A prospective interventional quasi-randomized interval clinical study." National Journal of Physiology, Pharmacy and Pharmacology 11.3 (2021), 246-252. Print. doi:10.5455/njppp.2021.11.10285202024102020 APA (American Psychological Association) Style R, A., Pillai, . S., S, . S. N., Aravindakshan, . R., G, . R. & Chandy, . S. J. (2021) Effectiveness and safety of ormeloxifene and medroxyprogesterone acetate in dysfunctional uterine bleeding A prospective interventional quasi-randomized interval clinical study. National Journal of Physiology, Pharmacy and Pharmacology, 11 (3), 246-252. doi:10.5455/njppp.2021.11.10285202024102020 |